Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma

Published:2019-09-06 Issue: Volume:25 Page:6691-6701
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Su Xiaolan¹,Wan Yang²,Xie Linshen²,Lin Xiufang³,Zhao Hongwen²,Ju Xiao⁴,Fang Aiping¹

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital and Healthy Food Evaluation Research Center, Sichuan University, Chengdu, Sichuan, China (mainland)

2. West China School of Public Health and West China Fourth Hospital, Healthy Food Evaluation Research Center, Sichuan University, Chengdu, Sichuan, China (mainland)

3. The Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China (mainland)

4. Sichuan Scientist Biotechnology Co., Ltd., Chengdu, Sichuan, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epistemology of the Origin of Cancer II: Fibroblasts Are the First Cells to Undergo Neoplastic Transformation;Cellular Physiology and Biochemistry;2023-12-27

2. The emerging roles of SUMOylation in pulmonary diseases;Molecular Medicine;2023-09-05

3. SUMOylation targeting mitophagy in cardiovascular diseases;Journal of Molecular Medicine;2022-09-26

4. Upregulation of long noncoding RNA linc02544 and its association with overall survival rate and the influence on cell proliferation and migration in lung squamous cell carcinoma;Discover Oncology;2022-05-30

5. Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299;Bioengineered;2022-04-01